Article Data

  • Views 530
  • Dowloads 127

Case Reports

Open Access

Malignant mixed Müllerian tumor of fallopian tube: report of a case and review of the literature

  • J. Bécsi1,*,
  • B. Szabó2
  • T. Szabó1
  • M. Onuș1
  • S. Mocan2
  • M. Căpîlna1

11st Clinic of Obstetrics and Gynaecology, University of Medicine and Pharmacy of Targu Mures, Romania

2Department of Pathology, University of Medicine and Pharmacy of Targu Mures, Romania

DOI: 10.12892/ejgo4142.2019 Vol.40,Issue 1,February 2019 pp.143-147

Accepted: 14 March 2017

Published: 10 February 2019

*Corresponding Author(s): J. Bécsi E-mail: becsijanos@yahoo.com

Abstract

Primary development of malignant mixed Müllerian tumor (MMMT) in the fallopian tube is a very rare pathology associated with negative prognosis. The authors report a new case of Stage III B tubal carcinosarcoma with no heterologous element. After the surgical radical procedure, a combined adjuvant chemotherapy was given and, after two years of follow-up, the patient shows no evidence of disease. A literature review of articles on this topic was conducted through a Medline search for articles published in English, and 63 patients with the same pathology were found. Data on symptoms, diagnosis, histological type, treatment, and prognosis were collected and statistically analyzed. As conclusion, the initial stages have better survival, with no effect of histological subtype. Presence of ascites had a negative prognostic value. Due to the limited number of cases reported, making the statistical analysis difficult, the authors consider mandatory to report this rare entity to ease the upcoming research.

Keywords

Carcinosarcoma; Fallopian tube; Malignant mixed Müllerian tumor; Heterologous component

Cite and Share

J. Bécsi,B. Szabó,T. Szabó,M. Onuș,S. Mocan, M. Căpîlna. Malignant mixed Müllerian tumor of fallopian tube: report of a case and review of the literature. European Journal of Gynaecological Oncology. 2019. 40(1);143-147.

References

[1] Rosenblatt K.A., Weiss N.S., Schwartz S.M.: “Incidence of malignant fallopian tube tumors”. Gynecol. Oncol., 1989, 35, 236.

[2] Hanjani P., Peterson R.O., Bonell S.A.: “Malignant Mixed Mullerian Tumor of the fallopian tube report of a case and review of literature”. Gynecol. Oncol., 1980, 9, 381.

[3] Alvarado-Cabrero I., Cheung A., Caduff R.: “Tumours of the fallopian tube. Pathology and genetics of the tumours of the breast and the female genital organs”. Lyon: IARC Press, 2003, 209.

[4] Arioz D.T., Yilmaz S., Okur N., Aktepe F., Yilmazer M., Ozalp S.: “Primary Malignant Mixed Müllerian Tumor of the fimbriated end of the fallopian tube causing hematosalpinx and hematometra”. N. Am. J. Med. Sci., 2012, 4, 659.

[5] Axelrod J.H., Herbold R., Freel J.H.: “Carcinosarcoma of the fallopian tube”. Gynecol. Oncol., 1989, 32, 398.

[6] Baloğlu A., Güven C.M., Yavuzcan A., ÇetinkayaB., Yiğit S.: “Simultaneous primary carcinosarcoma of the uterus and the bilateral fallopian tubes: an extremely rare case and review of the literature”. Gynecol. Surg., 2009, 6, 393.

[7] Carlson J.A., Ackerman B.L., Wheeler J.E.: “Malignant Mixed Mullerian Tumor of the fallopian tube”. Cancer, 1993, 71, 187.

[8] Tsai C.P., Ho E.S., Ke Y.M., Hsu S.T., Wang R.C., Lu C.H.: “Stage III malignant mixed Mullerian tumor of the fallopian tube: A case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin”. Taiwan J. Obstet. Gynecol., 2012 51, 294.

[9] Deppe G., Zbella E., Friberg J., Thomas M.: “Combination chemotherapy for mixed müllerian tumor of the Fallopian tube”. Cancer , 1984, 54, 1517.

[10] Gupta R., Jenison E.L.: “A rare case of carcinosarcoma of the fallopian tube presenting with torsion, rupture and hemoperitoneum”. Gynecol.Oncol. Rep., 2012, 2, 4.

[11] Hellström A.C, Auer G., Silfverswärd C., Pettersson F.:” Prognostic factors in malignant mixed Müllerian tumor of the fallopian tube: the Radiumhemmet series 1923-1994”. Int. J. Gynecol. Cancer, 1996, 6, 467.

[12] Horn L.C, Werschnik C., Bilek K., Emmert C.: “Diagnosis and efinical management in malignant Müllerian tumors of the fallopian tube. A report of four cases and review of recent literature”. Arch. Gynecol. Obstet., 1996, 258, 47.

[13] Imachi M., Tsukamoto N., Shigematsu T., Watanabe T., Veira K., Amada S., et al.: ‘Malignant Mixed Müllerian Tumor of the fallop- ian tube: report of two cases and review of literature”. Gynecol. Oncol., 1992, 47, 114.

[14] Kahanpaa K.V, Laine R., Saksela E.: “Malignant Mixed Müllerian Tumor of the fallopian tube: report of a case with 5 year survival”. Gynecol.Oncol., 1983, 16, 144.

[15] Kinoshita M., Aasano S., Yamashita M., Matsuda T.: “Mesodermal mixed tumor primary in the fallopian tube”. Gynecol. Oncol., 1989, 32, 331.

[16] Kourea H.P, Adonakis G., Androutsopoulos G., Zyli P., Kourounis G, Decavalas G.: “Fallopian tube malignant mixed mullerian tumor (carcinosarcoma): a case report with immunohistochemical profiling”. Eur. J .Gynaecol. Oncol., 2008, 29, 538.

[17] Kuroda N., Inui Y., Ohara M., Hirouchi T., Mizuno K., Kubo A., et al.: “Hyaline globule-like structures in undifferentiated sarcoma cells of malignant müllerian mixed tumor of the fallopian tube”. Med. Mol. Morphol., 2007, 40, 46.

[18] Kuroda N., Moriki T., Oguri H., Maeda N., Toi M., Miyazaki E., et al.: “Malignant müllerian mixed tumor (carcinosarcoma) of the fallopian tube: an immunohistochemical study of neoplastic cells”. APMIS, 2005, 113, 643.

[19] Lim B.J, Kim J.W., Yang W.I., Cho N.H.: “Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components”. Int. J. Gynecol. Cancer, 2004, 14, 690.

[20] Maitra R.N., Lee J., McConnell D.T., Kenwright D.N., Dady P.: “Malignant mixed mullerian tumour of the fallopian tube occurring in a patient with Peutz-Jegher’s syndrome”. Aust. N. Z. J. Obstet. Gynaecol., 2004, 44, 77.

[21] Manes J.L., Taylor H.B.: “Carcinosarcoma and mixed mullerian tumors of the fallopian tube. Report of four cases”. Cancer, 1976, 38, 1687.

[22] Moustafa M., Beynon D.W.G, Elmahallawy M.: “Primary malignant mixed Mullerian tumour of the fallopian tube”. J. Obstet. Gynaecol., 2004, 24, 940.

[23] Muntz H.G., Rutgers J.L., Tarraza H.M., Fuller A.F.: “Carcinosarcomas and mixed Müllerian tumors of the fallopian tube”. Gynecol. Oncol., 1989, 34, 109.

[24] Nappi L., Indraccolo U., Matteo M., Rosenberg P., Greco P.: “Malignant mixed mullerian tomor of the fallopian tube coincident with a primary serous carcinoama of the ovary. Case report”. Eur. J. Gynaecol. Oncol., 2007, 28, 511.

[25] Piura B., Rabinovichi A., Apel-Sarid L., Shaco-Levy R.: “Carcinosarcoma of the fallopian tube with metastasis of its epithelial component to the ovary, appendix and omentum”. J. Obstet. Gynaecol., 2009, 29, 566.

[26] Seraj I.M., King A., Chase D.: “Malignant Mixed Müllerian Tumor of the Oviduct”. Gynecol. Oncol., 1990, 37, 296.

[27] Shen Y.M., Xie Y.P., Xu L.,Yang K.W., Yu, N., Yu Y., Wang J.H.: ““Malignant mixed mullerian tumor of the fallopian tube: report of two cases and review of literature”. Arch. Gynecol. Obstet., 2010, 281, 1023.

[28] Skafida E., Grammatoglou X., Katsamagkou E., Glava C., Firfiris N., Vasilakaki T.: “Primary malignant mixed mullerian tumour of the fallopian tube. Report of a case”. Eur. J. Gynaecol. Oncol., 2010, 31, 126.

[29] Suzin J., Grzesiak M., Giernat L., Kowalski A.: “Heterologous form of the Malignant Mullerian Mixed Tumor of the fallopian tube. Literature review and case report. 7th Biennal Meeting of the International Gynecologic Cancer Society. Int. J. Gynecol. Cancer, 1999, 9, 154.

[30] Watanabe T., Sugino T., Furukawa S., Soeda S., Nishiyama H., Fujimori K.: “Malignant mixed Müllerian tumor of the fallopian tube: a case report”. Eur. J. Gynaecol. Oncol., 2012, 33, 223.

[31] Weber A.M., Hewett W.F., Gajewski W.H., Kurry S.L.: “Malignant mixed mullerian tumors of the fallopian tube”. Gynecol. Oncol., 1993, 50, 239.

[32] Yokoyama Y., Yokota M., Futagami M.: “Carcinosarcoma of the fallopian tube: Report of four cases and review of literature”. Asia Pac. J. Clin. Oncol., 2012, 8, 303.

[33] Zorlu C.G., Cobanoglu O., Kuşçu E., Aribas D.: “Malignant mixed müllerian tumor of the fallopian tube”. Acta Obstet. Gynecol. Scand., 1994, 73, 352.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top